Equity
€279,689 ▲ 54.6%
Equity rose in 2025 from €180,913 to €279,689.
Dr. I. Dewandel
Lifetime
3 annual accounts with figures on one time axispeak €135,258 (2023)
€126,918▲ 37.3%
peak €105,618 (2023)
€98,776▲ 35.7%
peak €279,689 (2025)
€279,689▲ 54.6%
€80,953▲ 2.8%
Board1 name since 2023
1 director
Documentsfilings and deeds
30-08-202630 days late
2025micro format
Gross margin from €92,413 to €126,918Result from €72,795 to €98,776Equity from €180,913 to €279,689Cash from €645 to €1,137
Key points
from the 2025 annual accountsChecked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 39,274 companies had the same profile as Dr. I. Dewandel has now. Each dot stands for 99 companies, two years later.
95.8%
were still trading
2.3%
stopped another way
1.8%
went bankrupt
Another 0.1% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,331 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 39,274 companies, not a prediction for Dr. I. Dewandel. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Recent changes
Registered-office move
Director in office: · Board meeting of 30-07-2025 · Gazette deed
Registered office moved within Nieuwpoort
New registered office: Albert I laan 2 bus 0401 te 8620 Nieuwpoort · Previous registered office: Albert 1 laan 101B bus 0.03 te 8620 Nieuwpoort · Board meeting of 02-05-2024 · Gazette deed
Incorporation
Founding capital of €2,500 · Founder: · Appointment: (director) · published on 22-09-2023 · Gazette deed
First establishment
Torhoutsesteenweg 171, Zedelgem
Official details
Source: KBO- Status
- Active since 20-09-2023Normal situation
- Activity
- “Het uitoefenen van de geneeskunde door een arts-aandeelhouder algemeen, onder meer - doch niet…” (deed in Dutch)From the articlesNo NACE code in the KBO yet
- Establishment unit
- 2.350.137.6758210 Zedelgem, since 20-09-2023
- Financial year end
- 31 December
- Peppol
- Not found in the Peppol Directory
Insights on Dr. I. Dewandel
Dr. I. Dewandel files the micro format. That format states no turnover. The gross margin fell from €135,258 in 2023 to €126,918 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about Dr. I. Dewandel
- What is the company number of Dr. I. Dewandel?
- The company number of Dr. I. Dewandel is 1000.082.569. The VAT number is the same number with BE in front: BE 1000.082.569.
- Where is Dr. I. Dewandel based?
- The registered office is at Torhoutsesteenweg 171, 8210 Zedelgem.Company details
- What is the legal form of Dr. I. Dewandel?
- Dr. I. Dewandel is a private limited company (BV).
- When was Dr. I. Dewandel founded?
- Dr. I. Dewandel was founded on 20-09-2023.
- Is Dr. I. Dewandel still active?
- Yes, Dr. I. Dewandel is an active enterprise in the KBO register.
- What is the turnover of Dr. I. Dewandel?
- The turnover in financial year 2025 is ≈ €320,000. This figure is estimated from the gross margin of €126,918 and 2,204 comparable companies of the same size. It probably lies between €210,000 and €490,000. It is a rough estimate.Financials
- Is Dr. I. Dewandel profitable?
- In financial year 2025, Dr. I. Dewandel made a profit of €98,776.
- Where can I find the annual accounts of Dr. I. Dewandel?
- Dr. I. Dewandel filed 3 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of Dr. I. Dewandel due?
- Dr. I. Dewandel must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.